| Alpha-Synuclein and the endolysosomal system in parkinson’s disease: guilty by association M Teixeira, R Sheta, W Idi, A Oueslati Biomolecules 11 (9), 1333, 2021 | 27 | 2021 |
| Switch of serotonergic descending inhibition into facilitation by a spinal chloride imbalance in neuropathic pain F Aby, LE Lorenzo, Z Grivet, R Bouali-Benazzouz, H Martin, S Valerio, ... Science Advances 8 (30), eabo0689, 2022 | 18 | 2022 |
| A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease M Bérard, R Sheta, S Malvaut, R Rodriguez-Aller, M Teixeira, W Idi, ... Plos Biology 20 (3), e3001578, 2022 | 13 | 2022 |
| Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons R Sheta, M Teixeira, W Idi, M Pierre, A de Rus Jacquet, V Emond, ... Scientific Reports 12 (1), 17176, 2022 | 9 | 2022 |
| Optimized protocol for the generation of functional human induced-pluripotent-stem-cell-derived dopaminergic neurons R Sheta, M Teixeira, W Idi, A Oueslati STAR protocols 4 (3), 102486, 2023 | 3 | 2023 |
| Optogenetic-Mediated Spatiotemporal Control of α-Synuclein Aggregation Mimics Lewy Body Formation and Triggers Neurodegeneration M Berard, R Sheta, S Malvaut, R Rodriguez-Aller, M Teixeira, W Idi, ... | 2 | 2021 |
| Alpha-Synuclein and the Endolysosomal System in Parkinson’s Disease: Guilty by Association. Biomolecules 2021, 11, 1333 M Teixeira, R Sheta, W Idi, A Oueslati s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 1 | 2021 |
| Optogenetic-mediated induction and monitoring of α-synuclein aggregation in cellular models of Parkinson’s disease M Teixeira, R Sheta, W Idi, A Oueslati STAR protocols 4 (4), 102738, 2023 | | 2023 |
